Proposed rituximab biosimilar BCD‐020 versus reference rituximab for treatment of patients with indolent non‐Hodgkin lymphomas: An international multicenter randomized trial
2019 ◽
2019 ◽
2019 ◽
Keyword(s):
2019 ◽
2019 ◽
Keyword(s):
2019 ◽
2019 ◽
2018 ◽
Vol 87
(6)
◽
pp. AB81
◽